Virtue insight is proud to present its 11th Biosimilars Congregation on 6th December 2017 at Kohinoor Continental Hotel, Mumbai, India. Discussing strategies for biosimilar product development Indian Pharmaceutical companies have started to look at biosimilars as a lucrative sector owing to the recent regulatory approvals and revenue generating opportunities. This event will discuss commercial strategies, insights on how regulatory & approval process work in region, opportunities for market expansion and highlights on R&D.
WHO SHOULD ATTEND:
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:
Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Biogenerics, Legal Affairs, Intellectual Property,Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science,Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affairs
CONFERENCE REGISTRATION PROCESSS:
You can e-mail your interest to Kavitha@virtueinsight.co.in OR Tel- +91 44 64998743
In order to register you can simply e-mail me your invoice details in the below mentioned format;
Join us to explore the current global climate for biosimilars, evaluate competition and benchmark with industry peers on how to navigate the changing regulations and landscape of the biosimilars market and effectively bring these programs to market.
For more details and updates please visit website.